Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Discover how targeting the A3 adenosine receptor (A3AR) with agonists like Cl-IB-MECA can inhibit breast cancer stem cells (BCSCs) and potentially transform breast cancer treatment.